← Back to Patent Explorer
US5085861A Expired / Lapsed US ⏱️ 0.0 years remaining

Bioerodable implant composition comprising crosslinked biodegradable polyesters

Assignee: Beth Israel Deaconess Medical Center
•
Filing: 1989-05-12
•
Granted: 1992-02-04
•
Expires: 2009-05-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved bone cement is comprised of a particulate biocompatible calcium phosphate ceramic and particulate resorbable calcium salt dispersed in a cross-linked biodegradable polyester matrix. The polymer/salt-particle composite exhibits good biomechanical strength/modulus characteristics with surgically acceptable cure times. When used for sustained release of biologically active agents in a physiological environment, controlled release of biological agents that are mixed into the composite can be achieved as the cement biodegrades. When used for bone/implant fixation, or as a filler or cement for bone repair, gradual biodegradation of the cement composite permits, under suitable circumstances, evantual replacement of the cement with developing bone tissue.

Inventors

  • 👤 Tobin N. Gerhart
  • 👤 Wilson C. Hayes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 03:05
CPC Classifications
C; C08; C08K; C08K3/00; C08K3/18; C08K3/24; A; A61; A61L; A61L24/00; A61L24/001; A61L24/0015; A61L24/0047; A61L24/0073; A61L24/0084; C08K3/32; A61F; A61F2/00; A61F2/02; A61F2/30; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2/46; A61F2002/4631; A61F2210/00; A61F2210/0004; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 71 words
A composition comprising a particulate biocompatible resorbable calcium salt, a sintered particulate calcium phosphate ceramic and a biologically active agent dispersed in a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol with about 5 to about 20% by weight of methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 2
Dependent Claim 71 words
A composition comprising a particulate biocompatible resorbable calcium salt, a sintered particulate calcium phosphate ceramic and a biologically active agent dispersed in a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol with about 5 to about 20% by weight of methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 3
Dependent Claim 22 words
The composition of claim 1 wherein said biologically active agent forms about 0.1 to about 33 percent by weight of the matrix.
Claim 4
Independent Claim 70 words
A method of repairing living bone which method comprises applying to said living bone a biodegradable bone cement for fixation of bone or joint prostheses, said bone cement comprising a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid with about 5 to about 20% by weight of methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 5
Independent Claim 70 words
A method of repairing living bone which method comprises applying to said living bone a biodegradable bone cement for fixation of bone or joint prostheses, said bone cement comprising a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid with about 5 to about 20% by weight of methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 6
Dependent Claim 47 words
The method of claim 3 wherein the biodegradable bone cement comprises methyl methacrylate cross-linked poly(propylene glycol fumarate), a calcium phosphate ceramic and a biocompatible resorbable calcium salt and wherein the weight ratio of the cross-linked polymer to ceramic plus salt is about 2:1 to about 1:5, respectively.
Claim 7
Dependent Claim 121 words
In the method of surgical repair of a bone or joint comprising use of a polymeric cement in contact with living bone, the improvement consisting essentially of preparing the polymeric cement by forming a dispersion of a particulate biocompatible calcium phosphate ceramic and a particulate biocompatible resorbable calcium salt in a mixture of a polymer matrix-forming fluid comprising a (1) a chemically cross-linkable biodegradable polyester of a dicarboxylic acid comprising fumaric acid having a number average molecular weight of about 500 to about 1200 and (2) about 5 to about 20% by weight methyl methacrylate as a cross-linking agent, and initiating a chemical reaction between the polyester and the cross-linking agent prior to using said cement in contact with living bone.
Claim 8
Dependent Claim 121 words
In the method of surgical repair of a bone or joint comprising use of a polymeric cement in contact with living bone, the improvement consisting essentially of preparing the polymeric cement by forming a dispersion of a particulate biocompatible calcium phosphate ceramic and a particulate biocompatible resorbable calcium salt in a mixture of a polymer matrix-forming fluid comprising a (1) a chemically cross-linkable biodegradable polyester of a dicarboxylic acid comprising fumaric acid having a number average molecular weight of about 500 to about 1200 and (2) about 5 to about 20% by weight methyl methacrylate as a cross-linking agent, and initiating a chemical reaction between the polyester and the cross-linking agent prior to using said cement in contact with living bone.
Claim 9
Dependent Claim 13 words
The improvement of claim 5 wherein the biodegradable polyester is poly(propylene glycol fumarate).
Claim 10
Dependent Claim 79 words
An implantable article for use in the sustained release of effective amounts of a biologically active agent into a physiological environment, said delivery system comprising a biologically active agent dispersed in a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol with about 5 to about 20% by weight methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 11
Dependent Claim 79 words
An implantable article for use in the sustained release of effective amounts of a biologically active agent into a physiological environment, said delivery system comprising a biologically active agent dispersed in a polymer matrix formed by cross-linking a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol with about 5 to about 20% by weight methyl methacrylate, said polyester having a number average molecular weight of about 500 to about 1200.
Claim 12
Dependent Claim 13 words
The article of claim 7 wherein the biologically active agent is an antibiotic.
Claim 13
Dependent Claim 51 words
A bioerodable polymer matrix composition comprising a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol cross-linked with about 5 to about 20% by weight of methyl methacrylate, said biodegradable polyester having a number average molecular weight of about 500 to about 1200.
Claim 14
Dependent Claim 51 words
A bioerodable polymer matrix composition comprising a biodegradable polyester of a dicarboxylic acid comprising fumaric acid and a polyhydric C 2 -C 6 alcohol cross-linked with about 5 to about 20% by weight of methyl methacrylate, said biodegradable polyester having a number average molecular weight of about 500 to about 1200.
Claim 15
Dependent Claim 16 words
The bioerodable composition of claim 9 wherein the C 2 -C 6 alcohol is propylene glycol.
Claim 16
Dependent Claim 18 words
The composition of claim 1 wherein the biodegradable polyester is a polyester of fumaric acid and propylene glycol.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-02-03 1995-08-05 1996-02-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-02-03 1999-08-05 2000-02-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-02-03 2003-08-05 2004-02-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag